Filing Details

Accession Number:
0001562180-17-003867
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-12-13 19:53:37
Reporting Period:
2017-12-11
Accepted Time:
2017-12-13 19:53:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1271214 Intersect Ent Inc. XENT Surgical & Medical Instruments & Apparatus (3841) 200280837
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1354228 Aaron David Lehman C/O Intersect Ent, Inc.
1555 Adams Drive
Menlo Park CA 94025
General Counsel No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-12-11 36,000 $18.00 45,000 No 4 M Direct
Common Stock Disposition 2017-12-11 36,000 $32.75 9,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2017-12-11 36,000 $0.00 36,000 $18.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
94,000 2026-02-21 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $33.00, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4.
  3. The vesting commencement date of the option is February 22, 2016. 25% of the shares subject to the option shall vest on February 22, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over three (3) years.